Shares of GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $20.68 and traded as low as $20.03. GENMAB A/S/S shares last traded at $20.92, with a volume of 1,872,721 shares.
GENMAB A/S/S Stock Performance
The company has a 50 day simple moving average of $20.67 and a 200-day simple moving average of $23.13.
About GENMAB A/S/S
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Recommended Stories
- Five stocks we like better than GENMAB A/S/S
- Profitably Trade Stocks at 52-Week Highs
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Want to Profit on the Downtrend? Downtrends, Explained.
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
